Picking up the tab for erythropoietin.
作者信息
Gabriel R
出版信息
BMJ. 1991 Feb 2;302(6771):248-9. doi: 10.1136/bmj.302.6771.248.
Abstract
摘要
相似文献
1
Picking up the tab for erythropoietin.为促红细胞生成素买单。
BMJ. 1991 Feb 2;302(6771):248-9. doi: 10.1136/bmj.302.6771.248.
2
Picking up the tab for erythropoietin.为促红细胞生成素买单。
BMJ. 1991 Feb 16;302(6773):407-8.
3
[Erythropoietin in the treatment of anemia in chronic renal insufficiency].促红细胞生成素治疗慢性肾功能不全贫血
An Med Interna. 1991 Jun;8 Suppl 2:22-3.
4
Erythropoietin: issues in its use as a therapeutic for the anemia of chronic renal failure.
Blood Purif. 1990;8(5):239-54. doi: 10.1159/000169974.
5
Erythropoietin for the anemia of chronic renal failure.
Am Fam Physician. 1988 Jun;37(6):211-5.
6
Erythropoietin.促红细胞生成素
S D J Med. 1990 Apr;43(4):13.
7
Possible involvement of soluble erythropoietin receptor in resistance to erythropoietin in patients with renal anemia.
Am J Nephrol. 2001 Sep-Oct;21(5):426. doi: 10.1159/000046289.
8
[Treatment of renal anemia using synthetic human erythropoietin].
Ther Umsch. 1988 Dec;45(12):895-9.
9
[Biological similarity of erythropoietin: controlled maturation].[促红细胞生成素的生物学相似性：可控成熟]
Nephrol Ther. 2009 Feb;5 Spec No1:1-2. doi: 10.1016/S1769-7255(09)70057-4.
10
[The role of erythropoietin].[促红细胞生成素的作用]
Soins. 2004 Sep(688 Suppl):5.
引用本文的文献
1
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.促红细胞生成素：关于其在慢性肾衰竭中的应用及其对生活质量影响的药物经济学综述。
Pharmacoeconomics. 1993 Jan;3(1):45-82. doi: 10.2165/00019053-199303010-00006.
2
Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.环孢素：肾移植中其应用的药物经济学评价
Pharmacoeconomics. 1993 Nov;4(5):366-95. doi: 10.2165/00019053-199304050-00007.
3
Picking up the tab for erythropoietin.承担促红细胞生成素的费用。
BMJ. 1991 Jun 1;302(6788):1335-6. doi: 10.1136/bmj.302.6788.1335-b.
4
Picking up the tab for erythropoietin.为促红细胞生成素买单。
BMJ. 1991 Mar 9;302(6776):592.
5
How to pay for expensive drugs.如何支付昂贵的药物费用。
BMJ. 1991 Sep 14;303(6803):593-4. doi: 10.1136/bmj.303.6803.593.
6
Picking up the tab for erythropoietin.承担促红细胞生成素的费用。
BMJ. 1991 Apr 13;302(6781):913. doi: 10.1136/bmj.302.6781.913-a.
7
General practitioner prescribing of erythropoietin.全科医生对促红细胞生成素的处方开具情况。
BMJ. 1991 Oct 26;303(6809):1063-4. doi: 10.1136/bmj.303.6809.1063-c.
8
The economics of prescribing.处方经济学
J R Coll Physicians Lond. 1992 Jan;26(1):66-8.
9
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.低剂量皮下注射促红细胞生成素对终末期肾病贫血患者的成本效益
BMJ. 1992 Feb 22;304(6825):474-7. doi: 10.1136/bmj.304.6825.474.
本文引用的文献
1
Over 50 and uremic equals death. The failure of the British National Health Service to provide adequate dialysis facilities.
Nephron. 1982;31(3):189-90. doi: 10.1159/000182644.
2
Negative selection of patients for dialysis and transplantation in the United Kingdom.英国透析和移植患者的阴性选择
Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1119-22. doi: 10.1136/bmj.288.6424.1119.
3
Treatment of renal anemia with recombinant human erythropoietin.重组人促红细胞生成素治疗肾性贫血
Am J Nephrol. 1989;9(5):353-62. doi: 10.1159/000167996.
4
Effects of withdrawing erythropoietin.停用促红细胞生成素的影响。
BMJ. 1991 Feb 2;302(6771):272-3. doi: 10.1136/bmj.302.6771.272-a.
Zotero 插件